dextrothyroxine has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajlaoui, K; Karray, M; Litaiem, N; Slouma, M; Zeglaoui, F | 1 |
1 other study(ies) available for dextrothyroxine and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |